Upcoming Events

Women in Medtech Forum

Wednesday, December 6, 2023 (8:30 AM - 11:00 AM) (EST)


Maternal care is one of the largest underserved areas in global healthcare, with the United States having the highest maternal mortality rate among developed nations. Within the United States, 36 percent of U.S. counties have been classified as maternity care deserts, defined as any county without a hospital or birth center offering obstetric care and without any obstetric providers. Racial and ethnic disparities only worsen the situation, with the maternal mortality rate for Black women an astounding 2.6 times higher than their white peers.

Being faced with a public health crisis, the current administration is striving to act on maternal health and the industry is responding, with global investment into maternal care significantly improving. What actions can be taken next?

MassMEDIC and Cambridge Consultants are convening prominent healthcare experts across industry and clinical practice to discuss the biggest unmet needs in maternal care, opportunities for innovation, and actions all stakeholders can be taking to improve outcomes for future generations. The panel will discuss the following topics:

  • The current state of maternal care in the US, including inequities, underserved communities, and barriers and facilitators to innovation.

  • Approaches and inventions that extend innovation across the care continuum, highlighting examples of how to break down existing barriers to achieve impact.

  • Actions that our community can take to support maternal health, starting today.

Please join MassMEDIC and Cambridge Consultants on December 6, 2023 for this in-person, panel discussion and networking reception.


8:30 AM - 9:00 AM – Registration & Networking 

9:00 AM - 10:30 AM – Panel Session

10:30 AM - 11:00 AM – Networking


Oli Qirko
President of North America
Cambridge Consultants

Oli has 20 years’ experience of helping leading global corporations to develop and commercialize breakthrough products and services in a range of markets. As the Cambridge Consultants North America president, leads an extraordinary team that partners with Fortune 100 and start-up companies to achieve transformational results through navigating deep tech innovation challenges. Oli holds a master’s in electrical engineering from WPI and an MBA from MIT. As well as serving on the WPI Engineering Advisory Board, Oli lectures at MIT Sloan School of Management. There, she mentors CXOs and executives on how to manage the most critical and complex organizational challenges in business, technology and global operations.

Huma Farid, MD
Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology
Harvard Medical School

Dr. Huma Farid is an obstetrician gynecologist at Beth Israel Deaconess Medical Center. She received her undergraduate degree in history from Harvard College and her MD from Harvard Medical School. She completed residency at Brigham and Women’s/Massachusetts General Hospital and then joined the faculty at Beth Israel Deaconess Medical Center, where she serves as the Director of the Colposcopy Clinic. She is a graduate of the Rabkin Fellowship in Medical Education and is the Associate Program Director for the Obstetrics and Gynecology Residency at BIDMC. She also serves as the Young Physician Representative for District I of the American College of Obstetricians and Gynecologists, the national organization for obstetrician gynecologists that is committed to championing reproductive health.

Maureen Halligan
Vice President of Advisory & Innovation Services

Cambridge Consultants

In her role at Cambridge Consultants, Marueen leads programs to define and delivery medical technology innovations. Maureen has over 10 years of experience in applying human-centered design approaches to identify unmet needs, translate these needs into product requirements, and implement solutions that meet requirements and promote an optimal user experience. She has worked on a myriad of medical technologies, with a focus in surgical innovations and digital health solutions. She holds a BS in Biomedical Engineering from the University of Virginia and an MS in Human Factors Engineering from Tufts University, where she previously taught Human Factors in Product Design. Maureen is a mother of two, and is passionate about creating mechanisms, communities, and innovations to better support women throughout and beyond the maternal care continuum.

Jennifer Law
Maternal Health Partnerships Lead

Jennifer Law leads maternal health partnerships at Philips, a leader in healthcare technology that aims to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. Jennifer champions innovative solutions—from remote fetal/maternal monitoring, to portable and AI-guided ultrasound, to the world’s most downloaded pregnancy app—to help close the care gap for millions of pregnant women who lack access to quality prenatal care in the U.S. and around the world.

Beyond her primary role, Jennifer is an active member of the HHS Maternal Mental Health Task Force, serving a two-year term where she applies her expertise to improve mental health care for mothers.

Prior to joining Philips, Jennifer was a consultant and award-winning book author, earning recognition from Consulting Magazine as a “35 under 35” Rising Star in 2021. Jennifer's global perspective is enriched by her experience as a Fulbright Scholar in South Korea, a program run by the U.S. State Department. This experience, along with her professional achievements, underscores her commitment to improving healthcare equity worldwide.

Jennifer is a graduate of Williams College and mom to two young children.

Liz Proos
Vice President of Product Development
Daré Bioscience

Liz Proos is the Vice President of Product Development at Daré Bioscience, a company focused on accelerating innovation in women’s health.  In this role Liz is responsible for technical and strategic product development, implementing best practice product development and program management approaches. She is also responsible for strategy and product development of DARE-LARC1, a user-controlled, long-acting, reversible contraceptive, leading a cross-functional R&D and product development team and key strategic external partners.  Liz joined Daré as part of the acquisition of DARE MB Inc. in November 2019.

Throughout her career Liz has developed and advanced novel products for numerous applications and therapeutic areas through clinical development, including bone substitute materials, pulmonary therapies, injectable sustained release products, and implantable drug delivery devices. During her 15-year tenure at DARE MB Inc., she developed the candidate formulation and managed the clinical program advancing the legacy company to its First-In-Human clinical study with parathyroid hormone, a treatment for osteoporosis. Liz also has significant preclinical testing experience and has worked closely with clinical, regulatory affairs, and marketing as a technical expert to advance complex product development and incorporate the user perspective, including a role at Becton Dickenson, where she worked in Medical Affairs as a technical liaison between R&D, clinical and business development groups, and conducted clinical studies for development of a novel continuous glucose monitoring product.

Liz has also held leadership and technical positions at BD, Lantheus Medical Imaging, Epic Therapeutics (a wholly owned subsidiary of Baxter Healthcare), and Etex Corporation. She has more than 25 years of experience in drug delivery science and product development of combination products and medical devices. Liz graduated from Wellesley College with a degree in Chemistry.


Cambridge Consultants, Inc.
2 Drydock Avenue Boston Suite 1210
Boston, MA 02110 United States
Wednesday, December 6, 2023 (8:30 AM - 11:00 AM) (EST)
Powered By GrowthZone